Biotech · Public company · San Diego, CA, US

Skye Bioscience, Inc.

Ticker SKYE · SEC CIK 0001516551

Track this companyFree. Adds Skye Bioscience, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials21 recruiting or active

Pipeline programs5From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline5

Nimacimab 300 mg injectionPhase 2 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
Nimacimab injectionPhase 2 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
SBI-100 Ophthalmic Emulsion, 0.5%Phase 2 · Primary Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
SBI-100 Ophthalmic Emulsion, 1.0%Phase 2 · Primary Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
semaglutide injectionPhase 2 · ObesityClinicalTrials.gov · fetched Nov 12, 2026

Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs PlaceboPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 22, 2024ClinicalTrials.gov NCT06577090 · fetched Nov 12, 2026
Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye PressurePHASE2 · COMPLETED · started Nov 9, 2023ClinicalTrials.gov NCT06144918 · fetched Nov 12, 2026